Add to ORKGEstrogens play a pivotal role in sexual development and reproduction and are also implicated in a number of physiological processes in various tissues including the cardiovascular system. Epidemiological evidence suggests that endogenous estrogens protect women against coronary heart disease (CHD) before the age of menopause, and decreased CHD risk among postmenopausal women has been for a long time the main expected benefit of hormone therapy (HT).1 However, from the publication of the Women Health Initiative (WHI) results,2 medical practices of HT have been dramatically altered
Hormone replacement therapy has long been advocated for protection against osteoporosis and for reli...
In the USA it is estimated that more than one million women become menopausal each year. Coronary he...
Extensive epidemiological observations, clinical mechanistic studies, and basic laboratory research...
The effects of estrogen and progestins on the vascular wall have drawn major medical attention, and ...
International audienceBefore menopause, women are protected from the risk of hypertension and athero...
International audienceEstrogens, and in particular 17β-estradiol (E2), play a pivotal role in sexual...
It is well known that cardiovascular disease is less frequentin premenopausal women compared with me...
1. Epidemiological studies indicate a lower incidence of coronary heart disease in premenopausal wom...
Coronary heart disease and estrogen plus progestin treatment: the “burden ” of the evidence Health p...
Heart disease is a major cause of illness and death in women. It is well known that there is an incr...
Coronary heart disease develops on average 10-15 years later in women than in men and is uncommon be...
International audienceCardiovascular disease has emerged as a leading cause of death in women. In re...
peer reviewedGender specific differences in cardiovascular disease are largely mediated by sex hormo...
Observational studies have consistently shown a markedly decreased risk of cardiovascular disease in...
Following the publication of the Women\u27s Health Initiative study, the controversy was raised rega...
Hormone replacement therapy has long been advocated for protection against osteoporosis and for reli...
In the USA it is estimated that more than one million women become menopausal each year. Coronary he...
Extensive epidemiological observations, clinical mechanistic studies, and basic laboratory research...
The effects of estrogen and progestins on the vascular wall have drawn major medical attention, and ...
International audienceBefore menopause, women are protected from the risk of hypertension and athero...
International audienceEstrogens, and in particular 17β-estradiol (E2), play a pivotal role in sexual...
It is well known that cardiovascular disease is less frequentin premenopausal women compared with me...
1. Epidemiological studies indicate a lower incidence of coronary heart disease in premenopausal wom...
Coronary heart disease and estrogen plus progestin treatment: the “burden ” of the evidence Health p...
Heart disease is a major cause of illness and death in women. It is well known that there is an incr...
Coronary heart disease develops on average 10-15 years later in women than in men and is uncommon be...
International audienceCardiovascular disease has emerged as a leading cause of death in women. In re...
peer reviewedGender specific differences in cardiovascular disease are largely mediated by sex hormo...
Observational studies have consistently shown a markedly decreased risk of cardiovascular disease in...
Following the publication of the Women\u27s Health Initiative study, the controversy was raised rega...
Hormone replacement therapy has long been advocated for protection against osteoporosis and for reli...
In the USA it is estimated that more than one million women become menopausal each year. Coronary he...
Extensive epidemiological observations, clinical mechanistic studies, and basic laboratory research...